Skip to main content
. 2013 Jan 25;123(2):563–565. doi: 10.1172/JCI67460

Figure 1. Regulation of CSC and bulk tumor cell population in prostate cancer.

Figure 1

(A) CSCs are regulated by androgen-independent pathways, involving α6β4 integrin that amplifies signaling through ErbB2 and c-Met pathways, which can be inhibited by lapatinib and crizotinib. (B) Bulk tumor cell growth is primarily regulated by androgens through interaction with AR and is sensitive to androgen blockade. Androgen signaling inhibits expression of Erbb2 and c-Met.